Tag Archives: Mino-Lok

Citius Pharma Raises $71 million in Equity Unit Offering

Posted on March 23, 2021 by Stephen Percoco

Citius Pharmaceuticals (CXTR) is a specialty pharmaceutical company focused on the development of four potential products: (1) Mino-Lok, an antibiotic lock solution to treat and salvage infected central venous catheters (“CVCs”) in patients with catheter-related bloodstream infections (“CRBSIs”); Halo-Lido, a … Continue reading →

Posted in CTXR, Health Care | Tagged , | Comments Off on Citius Pharma Raises $71 million in Equity Unit Offering